TNFRSF11A and osteosarcoma: Although a recent study shows that pulmonary osteosarcoma metastases have fewer osteoclasts48, earlier work has shown that patients with aggressive osteosarcomas often have increased osteoclast activity49 and that inhibition of osteoclast function via a RANK-ligand antagonist leads to favorable outcomes in mice50.